NEW YORK (GenomeWeb News) – Nanosys today said that it has licensed patents and patent applications covering the use of nanowires for biosensors to QuantuMDx Group.

The non-exclusive pact allows QuantuMDx to use the technology worldwide for DNA sequencing and biomarker detection applications. In exchange, QuantuMDx paid Palo Alto, Calif.-based Nanosys an upfront license fee and will make downstream royalty payments.

Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.